Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP51539.RArw9DgM4saZrMWMlZm_Ptge-8H5JcAbmJqGvphHCfI6Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP51539.RArw9DgM4saZrMWMlZm_Ptge-8H5JcAbmJqGvphHCfI6Y130_assertion type Assertion NP51539.RArw9DgM4saZrMWMlZm_Ptge-8H5JcAbmJqGvphHCfI6Y130_head.
- NP51539.RArw9DgM4saZrMWMlZm_Ptge-8H5JcAbmJqGvphHCfI6Y130_assertion description "[To fully evaluate SLC6A3 as a therapeutic antipshycotic target we investigated association of the gene with responses to chlorpromazine and clozapine and with chlorpromazine-induced extrapyramidal syndrome (EPS) in the Chinese schizophrenia population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP51539.RArw9DgM4saZrMWMlZm_Ptge-8H5JcAbmJqGvphHCfI6Y130_provenance.
- NP51539.RArw9DgM4saZrMWMlZm_Ptge-8H5JcAbmJqGvphHCfI6Y130_assertion evidence source_evidence_literature NP51539.RArw9DgM4saZrMWMlZm_Ptge-8H5JcAbmJqGvphHCfI6Y130_provenance.
- NP51539.RArw9DgM4saZrMWMlZm_Ptge-8H5JcAbmJqGvphHCfI6Y130_assertion SIO_000772 20580759 NP51539.RArw9DgM4saZrMWMlZm_Ptge-8H5JcAbmJqGvphHCfI6Y130_provenance.
- NP51539.RArw9DgM4saZrMWMlZm_Ptge-8H5JcAbmJqGvphHCfI6Y130_assertion wasDerivedFrom gad-20130706 NP51539.RArw9DgM4saZrMWMlZm_Ptge-8H5JcAbmJqGvphHCfI6Y130_provenance.
- NP51539.RArw9DgM4saZrMWMlZm_Ptge-8H5JcAbmJqGvphHCfI6Y130_assertion wasGeneratedBy ECO_0000203 NP51539.RArw9DgM4saZrMWMlZm_Ptge-8H5JcAbmJqGvphHCfI6Y130_provenance.